The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARROWHEAD PHARMACEUTICALS IN COM 04280A100   25,982,356 908,474 SH   SOLE   908,474 0 0
ARVINAS INC COM 04335A105   16,750,020 405,766 SH   SOLE   405,766 0 0
BLUEPRINT MEDICINES CORP COM 09627Y109   17,278,844 182,151 SH   SOLE   182,151 0 0
KYMERA THERAPEUTICS INC COM 501575104   15,627,469 388,743 SH   SOLE   388,743 0 0
MERUS N V COM N5749R100   11,487,558 255,109 SH   SOLE   255,109 0 0
PRECISION BIOSCIENCES INC COM NEW 74019P207   5,226,566 385,440 SH   SOLE   385,440 0 0
REGENXBIO INC COM 75901B107   19,094,645 906,248 SH   SOLE   906,248 0 0
REPARE THERAPEUTICS INC COM 760273102   2,982,706 633,271 SH   SOLE   633,271 0 0
SILENCE THERAPEUTICS PLC ADS 82686Q101   12,403,022 574,214 SH   SOLE   574,214 0 0
SUTRO BIOPHARMA INC COM 869367102   6,584,883 1,165,466 SH   SOLE   1,165,466 0 0